14.11.2022 • NewsLyondellBasellpetrochemical companyShell

LyondellBasell Wins PP Projects in China, Vietnam

LyondellBasell has won contracts for two PP projects, one in China and the other in Vietnam. The value of the contracts was not disclosed.

© Shutterstock/mmx
© Shutterstock/mmx

China’s CNOOC and Shell Petrochemicals Company (CSPC) have selected LyondellBasell’s Spherizone technology for a 500,000 t/y year plant to be installed at their joint venture complex in Huizhou, Guangdong province.

“This represents the second Spherizone line from a total of five polyolefin lines, licensed from LyondellBasell at the Huizhou site,” said Neil Nadalin, director, global licensing and services for LyondellBasell. “Spherizone process technology continues to demonstrate the ability to produce differentiated polymer grades in the highly competitive Chinese market, which remains a key requirement for our customers.”

A second contract for Spherizone technology came from Stavian Quang Yen Petrochemical for a 600,000 t/y PP plant to be built in Quang Ninh province, Vietnam. Nadalin said the plant will be Stavian’s first polyolefin facility, allowing them to serve the fast-growing Vietnamese market.

Author: Elaine Burridge, Freelance Journalist

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.